This week, we spoke with Nina Shah, MD and Sandy Wong, MD, both of the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, to discuss the predictive value of minimal residual disease and the need for treatment in a patient with smoldering multiple myeloma.